Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
V275278-2mg | 2mg | In stock | $42.90 | |
V275278-5mg | 5mg | In stock | $88.90 | |
V275278-10mg | 10mg | In stock | $147.90 | |
V275278-25mg | 25mg | In stock | $310.90 | |
V275278-50mg | 50mg | In stock | $559.90 | |
V275278-100mg | 100mg | In stock | $1,007.90 | |
V275278-250mg | 250mg | In stock | $2,267.90 |
Highly selective, competitive muscarinic M 1 antagonist
Synonyms | AKOS024457774 | A894354 | N-[3-oxo-3-(4-pyridin-4-ylpiperazin-1-yl)propyl]-2,1,3-benzothiadiazole-4-sulfonamide | VU0255035 hydrate | CS-0027615 | N-{3-oxo-3-[4-(pyridin-4-yl)piperazin-1-yl]propyl}-2,1,3-benzothiadiazole-4-sulfonamide | VU0255035 | BRD-K5 |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Highly selective, competitive muscarinic M 1 antagonist (K i = 14.87 nM). 75-fold selectivity over other receptor subtypes for orthosteric site. Blood-brain barrier permeable. |
Storage Temp | Store at -20°C,Desiccated |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of M 1 receptor;Antagonist of M 2 receptor;Antagonist of M 3 receptor;Antagonist of M 4 receptor;Antagonist of M 5 receptor |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | VU 0255035 is a highly selective, competitive and brain penetrant muscarinic M1 receptor antagonist with an IC50 of 130 nM. VU 0255035 reduces pilocarpine-induced seizures in mice. VU0255035 is used to examine the role of the M1 receptor in diverse situations |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | N-[3-oxo-3-(4-pyridin-4-ylpiperazin-1-yl)propyl]-2,1,3-benzothiadiazole-4-sulfonamide |
---|---|
INCHI | InChI=1S/C18H20N6O3S2/c25-17(24-12-10-23(11-13-24)14-4-7-19-8-5-14)6-9-20-29(26,27)16-3-1-2-15-18(16)22-28-21-15/h1-5,7-8,20H,6,9-13H2 |
InChi Key | WXDHQWPQLKGANZ-UHFFFAOYSA-N |
Canonical SMILES | C1CN(CCN1C2=CC=NC=C2)C(=O)CCNS(=O)(=O)C3=CC=CC4=NSN=C43 |
Isomeric SMILES | C1CN(CCN1C2=CC=NC=C2)C(=O)CCNS(=O)(=O)C3=CC=CC4=NSN=C43 |
PubChem CID | 24768606 |
Molecular Weight | 432.51 |
CAS Registry No. | 1135243-19-4 |
---|---|
PubChem CID | 24768606 |
ChEMBL Ligand | CHEMBL1628667 |
GPCRdb Ligand | VU0255035 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
F23061542 | Certificate of Analysis | Jun 12, 2024 | V275278 |
F23062010 | Certificate of Analysis | May 10, 2024 | V275278 |
F23061981 | Certificate of Analysis | May 10, 2024 | V275278 |
F23061980 | Certificate of Analysis | May 10, 2024 | V275278 |
F23061632 | Certificate of Analysis | May 10, 2024 | V275278 |
F23061568 | Certificate of Analysis | May 10, 2024 | V275278 |
F23061549 | Certificate of Analysis | May 10, 2024 | V275278 |
F23061565 | Certificate of Analysis | Mar 21, 2024 | V275278 |
F23061959 | Certificate of Analysis | Mar 21, 2024 | V275278 |
F23061978 | Certificate of Analysis | Mar 21, 2024 | V275278 |
F23062006 | Certificate of Analysis | Mar 21, 2024 | V275278 |
F23062008 | Certificate of Analysis | Mar 21, 2024 | V275278 |
F23062009 | Certificate of Analysis | Mar 21, 2024 | V275278 |
F23062051 | Certificate of Analysis | Mar 21, 2024 | V275278 |
Solubility | Soluble in DMSO to 50mM |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |